Is someone expecting bad news? I don't know why the market is reacting the way it is. Zacks gave it a $6 target and it exceeded the $3.25 target they gave it in August, plus they are making progress getting to a senior exchange. I would have assumed investors would act more favorably this.
"SAN DIEGO, April 3, 2013, Organovo Holdings, Inc. (OTCQX: ONVO) (“Organovo”), a three-dimensional biology company focused on
delivering breakthrough 3D bioprinting technology, announced today that the Company’s Board of Directors has approved a fiscal year-end
change from December 31st to March 31st, beginning on March 31, 2013. With this change, Organovo’s current fiscal year began on April 1st
and will end on March 31st each year.
The change in fiscal year is in alignment with the Company’s intention to apply for an initial listing on the NYSE or NASDAQ at the earliest